MedMira Inc.

TSXV:MIR Stock Report

Market Cap: CA$68.5m

MedMira Management

Management criteria checks 4/4

MedMira's CEO is Hermes Chan, appointed in Jul 2006, has a tenure of 18.5 years. total yearly compensation is CA$100.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.39% of the company’s shares, worth CA$267.19K. The average tenure of the management team and the board of directors is 10.9 years and 5.7 years respectively.

Key information

Hermes Chan

Chief executive officer

CA$100.0k

Total compensation

CEO salary percentage100.0%
CEO tenure18.5yrs
CEO ownership0.4%
Management average tenure10.9yrs
Board average tenure5.7yrs

Recent management updates

We Take A Look At Whether MedMira Inc.'s (CVE:MIR) CEO May Be Underpaid

Jan 29
We Take A Look At Whether MedMira Inc.'s (CVE:MIR) CEO May Be Underpaid

Here's What We Think About MedMira's (CVE:MIR) CEO Pay

Jan 20
Here's What We Think About MedMira's (CVE:MIR) CEO Pay

Recent updates

We Take A Look At Whether MedMira Inc.'s (CVE:MIR) CEO May Be Underpaid

Jan 29
We Take A Look At Whether MedMira Inc.'s (CVE:MIR) CEO May Be Underpaid

Here's What We Think About MedMira's (CVE:MIR) CEO Pay

Jan 20
Here's What We Think About MedMira's (CVE:MIR) CEO Pay

CEO Compensation Analysis

How has Hermes Chan's remuneration changed compared to MedMira's earnings?
DateTotal CompensationSalaryCompany Earnings
Oct 31 2024n/an/a

-CA$4m

Jul 31 2024CA$100kCA$100k

-CA$3m

Apr 30 2024n/an/a

-CA$3m

Jan 31 2024n/an/a

-CA$3m

Oct 31 2023n/an/a

-CA$3m

Jul 31 2023CA$100kn/a

-CA$3m

Apr 30 2023n/an/a

-CA$2m

Jan 31 2023n/an/a

-CA$2m

Oct 31 2022n/an/a

-CA$2m

Jul 31 2022CA$100kCA$100k

-CA$2m

Apr 30 2022n/an/a

-CA$2m

Jan 31 2022n/an/a

-CA$2m

Oct 31 2021n/an/a

-CA$2m

Jul 31 2021CA$100kCA$100k

-CA$676k

Apr 30 2021n/an/a

-CA$309k

Jan 31 2021n/an/a

-CA$663k

Oct 31 2020n/an/a

-CA$862k

Jul 31 2020CA$151kCA$151k

-CA$2m

Apr 30 2020n/an/a

-CA$2m

Jan 31 2020n/an/a

-CA$2m

Oct 31 2019n/an/a

-CA$2m

Jul 31 2019CA$191kCA$191k

-CA$2m

Apr 30 2019n/an/a

-CA$2m

Jan 31 2019n/an/a

-CA$2m

Oct 31 2018n/an/a

-CA$2m

Jul 31 2018CA$193kCA$188k

-CA$3m

Compensation vs Market: Hermes's total compensation ($USD69.53K) is below average for companies of similar size in the Canadian market ($USD166.93K).

Compensation vs Earnings: Hermes's compensation has been consistent with company performance over the past year.

CEO

Hermes Chan

18.5yrs

Tenure

CA$100,000

Compensation

Mr. Hermes Chan Co-Founded MedMira Inc. and has been its President since 2000 and Chief Executive Officer since July 24, 2006. Mr. Chan has been the Chief Executive Officer and President of MedMira Laborat...

Leadership Team

NamePositionTenureCompensationOwnership
Hermes Chan
Co-Founder18.5yrsCA$100.00k0.39%
CA$ 267.2k
Markus Meile
Chief Financial Officer10.5yrsCA$60.00kno data
Sam Ratnam
Director of Scientific & Regulatory Affairs2.3yrsno datano data
Stewart McKelvey
Legal Counselno datano datano data
Kevin Jones
Head of Commercialization and Senior Director of Sales & Marketing11.3yrsno datano data

10.9yrs

Average Tenure

Experienced Management: MIR's management team is seasoned and experienced (10.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Hermes Chan
Co-Founder24.8yrsCA$100.00k0.39%
CA$ 267.2k
Steven Cummings
Independent Director5.7yrsno datano data
Pascale Nini
Independent Director2.5yrsno datano data
Thomas Bergmann
Independent Chairman3.1yrsno datano data
Jianhe Mao
Independent Director5.7yrsno datano data

5.7yrs

Average Tenure

Experienced Board: MIR's board of directors are considered experienced (5.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 12:16
End of Day Share Price 2024/12/31 00:00
Earnings2024/10/31
Annual Earnings2024/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MedMira Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution